Rivaroxaban (Xarelto) Picks Up New VTE Indication in Acutely Ill
The new indication provides an oral-only option for acutely ill medical patients, and is the eighth to date granted by the FDA to the direct oral anticoagulant.
Related Articles
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Advancing the Prevention and Treatment of Heart Failure
In this free symposium, experts discuss current and emerging treatment options for the prevention and treatment of HF, across a spectrum of ejection fractions. Join…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
A Pulse on Innovation at the Heart of Cardiology 2025 – PMLiVE
MedscapeLIVE! is proud to present its annual Heart of Cardiology meeting, returning for its fifth year in Miami, Florida from January 24-26, 2025. Over 3
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…